The trademark application GHEMAXAN was filed by Chemi S.p.A., a corporation established under the laws of the Italian Republic (the "Applicant"). The application was published for oppositions on September 22, 2020, and it was registered by office on December 31, 2020 without any oppositions.
The application was filed in Italian (English was selected as the second language).
Goods And Services
The mark was filed in class 5 with Pharmaceuticals, specifically anticoagulants based on enoxaparin sodium for use in pre and post-surgery prophylactic treatment of venous thromboembolic diseases, associated with general surgery, orthopaedic and cancer operations, prophylaxis and treatment of deep vein thrombosis (DVT) and Anticoagulants..